Dapagliflozin attenuates diabetic cardiomyopathy through erythropoietin up-regulation of AKT/JAK/MAPK pathways in streptozotocin-induced diabetic rats-Reference-Cited by-同舟云学术

Dapagliflozin attenuates diabetic cardiomyopathy through erythropoietin up-regulation of AKT/JAK/MAPK pathways in streptozotocin-induced diabetic rats

Published:2021-09 Issue: Volume:347 Page:109617
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

El-Sayed Nora,Mostafa Yasser M.,AboGresha Noha M.,Ahmed Amal A.M.,Mahmoud Islam Z.,El-Sayed Norhan M.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference35 articles.

1. SGLT2 inhibitors: a Review of their antidiabetic and cardioprotective effects;Tentolouris;Int. J. Environ. Res. Publ. Health,2019

2. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity;Jia;Circ. Res.,2018

3. Exogenous spermine ameliorates high glucose-induced cardiomyocytic apoptosis via decreasing reactive oxygen species accumulation through inhibiting p38/JNK and JAK2 pathways;He;Int. J. Clin. Exp. Pathol.,2015

4. Cardiomyopathy associated with diabetes: the central role of the cardiomyocyte;Filardi;Int. J. Mol. Sci.,2019

5. Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study;Fujita;Sci. Rep.,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: Lessons from preclinical studies;Chemico-Biological Interactions;2024-11

2. SGLT2 inhibitor Dapagliflozin alleviates cardiac dysfunction and fibrosis after myocardial infarction by activating PXR and promoting angiogenesis;Biomedicine & Pharmacotherapy;2024-08

3. Role and molecular mechanisms of SGLT2 inhibitors in pathological cardiac remodeling (Review);Molecular Medicine Reports;2024-03-11

4. Elucidating the pharmacodynamic mechanisms of Yuquan pill in T2DM rats through comprehensive multi-omics analyses;Frontiers in Pharmacology;2023-11-17

5. Impact of Fixed Combination of Metformin and Pioglitazone on Insulin Resistance of Patients with Type 2 Diabetes: Results of a Randomized Open-Label Study;Diabetes, Metabolic Syndrome and Obesity;2023-09